1 week Ago By ABMN Staff
Astera Labs ( NASDAQ:ALAB – Get Free Report ) was downgraded by equities research analysts at Northland Capmk from a “strong-buy” rating to a “hold” rating in a research note issued on Thursday, Zacks.com reports. Other research analysts have also issued reports about the company.
Craig Hallum lifted their target price on Astera Labs from $75.00 to $105.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th.
Barclays lifted their price objective on Astera Labs from $70.00 to $87.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th.
Stifel Nicolaus increased their target price on Astera Labs from $80.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th.
Needham & Company LLC reaffirmed a “buy” rating and issued a $65.00 price target on shares of Astera Labs in a research note on Wednesday, October 9th. Finally, Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating and increased their price objective for the stock from $100.
00 to $120.00 in a research report on Thursday. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company.
According to data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.58.
Get Our Latest Stock Analysis on Astera Labs Astera Labs Stock Up 1.6 % Astera Labs ( NASDAQ:ALAB – Get Free Report ) last issued its earnings results on Monday, November 4th. The company reported $0.
23 EPS for the quarter, beating the consensus estimate of $0.17 by $0.06.
The firm had revenue of $113.10 million during the quarter, compared to the consensus estimate of $97.50 million.
Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%.
The business’s revenue was up 47.1% compared to the same quarter last year. As a group, research analysts expect that Astera Labs will post -0.
45 EPS for the current year. Insider Buying and Selling at Astera Labs In other Astera Labs news, Director Jack R. Lazar sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th.
The stock was sold at an average price of $61.69, for a total value of $185,070.00.
Following the completion of the transaction, the director now directly owns 137,000 shares in the company, valued at $8,451,530. This trade represents a 2.14 % decrease in their ownership of the stock.
The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link . Also, CFO Michael Truett Tate sold 100,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $62.
03, for a total value of $6,203,000.00. Following the sale, the chief financial officer now owns 1,762,888 shares in the company, valued at approximately $109,351,942.
64. This represents a 5.37 % decrease in their position.
The disclosure for this sale can be found here . In the last three months, insiders have sold 1,978,119 shares of company stock worth $186,618,509. Institutional Inflows and Outflows A number of hedge funds and other institutional investors have recently modified their holdings of ALAB.
FMR LLC lifted its position in shares of Astera Labs by 0.7% in the third quarter. FMR LLC now owns 23,504,038 shares of the company’s stock valued at $1,231,377,000 after buying an additional 153,491 shares during the last quarter.
Fred Alger Management LLC raised its stake in Astera Labs by 1,361.0% in the 3rd quarter. Fred Alger Management LLC now owns 2,821,921 shares of the company’s stock valued at $147,840,000 after acquiring an additional 2,628,765 shares during the period.
JPMorgan Chase & Co. lifted its holdings in Astera Labs by 3.1% during the 3rd quarter.
JPMorgan Chase & Co. now owns 1,568,314 shares of the company’s stock valued at $82,164,000 after purchasing an additional 47,569 shares during the last quarter. Maverick Capital Ltd.
boosted its position in Astera Labs by 16.0% during the third quarter. Maverick Capital Ltd.
now owns 1,156,230 shares of the company’s stock worth $60,575,000 after purchasing an additional 159,480 shares during the period. Finally, Westfield Capital Management Co. LP acquired a new position in shares of Astera Labs in the third quarter valued at $52,049,000.
Institutional investors own 60.47% of the company’s stock. About Astera Labs ( Get Free Report ) Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure.
Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale. Featured Stories Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter .
.
